SCHEMBL224100

SCHEMBL224100

CC(C)CCOC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL222547 0.86 CHRNB2 (0.53)
SCHEMBL13246917 0.84 CHRNB2 (0.52)
SCHEMBL27756492 0.83 CHRNB2 (0.52)
SCHEMBL29112544 0.83
SCHEMBL10465304 0.83
SCHEMBL18641519 0.83
SCHEMBL24632190 0.82 CHRNB2 (0.50)
SCHEMBL11126001 0.82 CHRNB2 (0.55)
SCHEMBL11248277 0.82 CHRNB2 (0.50)
SCHEMBL28945769 0.82 CHRNB2 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051665-B1 PHOTOPOLYMERIZATION COMPOSITIONS INCLUDING MALEIMIDES AND PROCESSES FOR USING THE SAME ALBEMARLE CORP (US) 2006-07-12 EP claimed
EP-0639585-A1 Elastase inhibitor BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-02-22 EP claimed
US-6410778-B1 None US disclosed
CN-110621678-B Antitumor compounds 法马马有限公司 2024-09-20 CN disclosed
EP-3957627-B1 6-MEMBERED HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SHIONOGI & CO (JP) 2024-06-19 EP disclosed
CN-114751920-B Antitumor compounds 法马马有限公司 2024-06-07 CN disclosed
CN-114736219-B Antitumor compounds 法马马有限公司 2024-06-07 CN disclosed
WO-2024096067-A1 CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING NEUROPATHIC PAIN AND/OR INFLAMMATORY PAIN 第一工業製薬株式会社 2024-05-10 WO disclosed
WO-2024094637-A1 PROCESS FOR THE PREPARATION OF CYCLIC KETONES ARXADA AG (CH) 2024-05-10 WO disclosed
WO-2024096066-A1 CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING CENTRAL NERVOUS SYSTEM INJURY/DISEASE 第一工業製薬株式会社 2024-05-10 WO disclosed
EP-4361148-A1 HETEROCYCLOALKYL-SUBSTITUTED POLYHETEROAZOLE DERIVATIVE AS MEDICAL DRUG FOR TREATMENT AND/OR PREVENTION OF RS VIRUS INFECTIOUS DISEASE Albius Sciences Alpha Private Limited (SG) 2024-05-01 EP disclosed
US-4497963-A ETHYLENICALLY UNSATURADED POLYMERS BASF AKTIENGESELLSCHAFT (DE) 1985-02-05 US disclosed
US-4459236-A Preparation of 1-alkenyl isocyanates BASF AKTIENGESELLSCHAFT (DE) 1984-07-10 US disclosed
US-4436668-A FROM CARBAMATE AND ALCOHOL BASF AKTIENGESELLSCHAFT (DE) 1984-03-13 US disclosed
US-4381403-A Process for the preparation of N-monosubstituted carbamic acid esters ATLANTIC RICHFIELD COMPANY (US) 1983-04-26 US disclosed
US-4375000-A Process for the preparation of an aryl mono-, di-, and/or polyurethane BASF AKTIENGESELLSCHAFT (DE) 1983-02-22 US disclosed
US-4349484-A Process for the manufacture of mixtures of diphenylmethane diisocyanates and polyphenyl polymethylene polyisocyanates BASF AKTIENGESELLSCHAFT (DE) 1982-09-14 US disclosed
US-4336402-A Process for the preparation of N-alkyl-monosubstituted carbamic acid esters ATLANTIC RICHFIELD COMPANY (US) 1982-06-22 US disclosed
US-4290970-A Process for the manufacture of aromatic di- and/or polyisocyanates BASF AKTIENGESELLSCHAFT (DE) 1981-09-22 US disclosed
US-4278805-A FROM AROMATIC AMINE, CARBAMATE AND ALCOHOL; METAL COMPOUND CATALYST BASF AKTIENGESELLSCHAFT (DE) 1981-07-14 US disclosed